Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bayer-Regeneron Eylea 8 mg approved in China for wet age-related macular degeneration

Ruchika Sharma22 May 2025 3:30 PM IST

Berlin: Bayer has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for Eylea 8...

Eli Lilly Kisunla secures Australian nod for early symptomatic Alzheimer's disease

Ruchika Sharma22 May 2025 2:29 PM IST

Indianapolis: Eli Lilly and Company has received marketing authorization from the Australian Therapeutic Goods Administration (TGA) for...

Sanofi to buy Vigil Neuroscience in USD 470 million deal

Ruchika Sharma22 May 2025 12:33 PM IST

Paris: Sanofi has announced that it has entered into an agreement to acquire Vigil Neuroscience, Inc., a publicly traded clinical-stage...

Malaysia extends Insulins supply contract with Biocon Biologics arm, Duopharma Marketing for additional six months

Malaysia extends Insulins supply contract with Biocon Biologics arm, Duopharma Marketing for additional 6 months

Ruchika Sharma22 May 2025 11:30 AM IST

Bengaluru: Biocon Biologics Limited has announced that the Government of Malaysia has agreed to extend the current contract period of 36 months...

Torrent Pharma appoints Aman Mehta as MD

Third-Gen Leadership: Aman Mehta set to lead Torrent Pharma as MD

Ruchika Sharma21 May 2025 4:57 PM IST

Ahmedabad: Torrent Pharma has announced the appointment of Aman Mehta, third generation of Torrent Group's founder Mehta family, as...

Medtronic announces intent to separate Diabetes business

Medtronic to spin off diabetes business

Ruchika Sharma21 May 2025 4:15 PM IST

Ireland: Medtronic plc has announced its intent to separate its Diabetes business into a new standalone company.The separation is expected to be...

Dont throw in the bin, please flush it! CDSCO dictum for these 17 medicines

Neurotrophin peptidomimetic drugs offer promise for treating neurodegenerative disorders, finds researchers

Ruchika Sharma21 May 2025 3:30 PM IST

Neurotrophin peptidomimetic drugs offer promise for treating neurodegenerative disorders, finds researchersNew Delhi: Peptidomimetic drugs - or...

Bayer Jivi gets USFDA approval for pediatric patients 7 years of age and older with hemophilia A

Ruchika Sharma21 May 2025 2:50 PM IST

The approval is based on data from the Alfa-PROTECT and PROTECT Kids studies.

USFDA Advisory Committee reviews Roche Columvi Combo for diffuse large B-cell Lymphoma

Ruchika Sharma21 May 2025 1:45 PM IST

Basel: Roche has announced that a US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) discussed the supplemental...

Biocon Biologics commercial partner launches psoriatic arthritis injection in Japan

Ruchika Sharma21 May 2025 12:29 PM IST

Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis.

Bharat Biotech Oral Cholera vaccine Hillchol shows success in Phase III clinical studies

Bharat Biotech Oral Cholera vaccine Hillcholl shows success in Phase III studies

Ruchika Sharma21 May 2025 11:30 AM IST

Hyderabad: Bharat Biotech's Oral Cholera Vaccine Hillchol has demonstrated against both Ogawa and Inaba serotypes, proving non-inferior in...

Cipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer

Cipla arm to acquire 26% stake in AMPIN Energy C&I Eighteen

Ruchika Sharma20 May 2025 5:23 PM IST

Mumbai: Pharmaceutical giant Cipla Ltd. has announced that Jay Precision Pharmaceuticals Private Limited, a subsidiary of the Company, will acquire...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok